Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2014
08/19/2014US8809000 Methods of screening heteromeric T1R2/T1R3 receptors for compounds which modulate sweet taste signaling
08/19/2014US8808999 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
08/19/2014US8808705 Polyvalent chimeric OspC vaccinogen and diagnostic antigen
08/19/2014US8808697 Methods of use of soluble CD24 for therapy of rheumatoid arthritis
08/19/2014US8808691 Method for treating tumors and their metastases
08/19/2014US8808685 Method of treatment using organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1α
08/19/2014US8808684 Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction
08/19/2014US8808666 Peptides that specifically target amyloid deposits
08/19/2014US8808664 Lipidated glycoprotein particles and methods of use
08/19/2014CA2690668C Vaccines containing canine parvovirus genetic variants
08/19/2014CA2675231C A conjugate comprising angiostatin or its fragment, the method for producing the conjugate and use thereof
08/19/2014CA2614972C Human anti-b7rp1 neutralizing antibodies
08/19/2014CA2572707C Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
08/19/2014CA2552882C Methods for diagnosis and prognosis of cancers of epithelial origin
08/19/2014CA2507844C Brassica ahas genes and gene alleles that provide resistance to imidazolinone herbicides
08/19/2014CA2503838C Peptide-based conditioners and colorants for hair
08/19/2014CA2482718C Derivatives of the il-2 receptor gamma chain, their production and use
08/19/2014CA2426200C Inhibition or reversal of skin aging by actin-sequestering peptides
08/19/2014CA2375106C Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
08/19/2014CA2364492C Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
08/14/2014WO2014124319A2 Human adaptation of h5 influenza
08/14/2014WO2014124301A1 Self-assembling protein nanostructures
08/14/2014WO2014124217A1 A selective high-affinity immune stimulatory reagent and uses thereof
08/14/2014WO2014124020A1 Method for selecting agents that bind to transmembrane receptors in a conformationally-selective manner
08/14/2014WO2014124017A1 Fibronectin type iii domain proteins with enhanced solubility
08/14/2014WO2014123761A1 Photoactive silk protein and fabrication of silk protein structures using photolithography
08/14/2014WO2014122653A1 Process for preparing insulin
08/14/2014WO2014122651A1 Process for preparing insulin
08/14/2014WO2014122613A1 Anti-il-17a antibodies and their use in treating autoimmune and inflammatory disorders
08/14/2014WO2014122449A1 Cyclodextrin glucanotransferase
08/14/2014WO2014122448A1 Production of butanol
08/14/2014WO2014122328A1 Efficient production of steviol glycosides in recombinant hosts
08/14/2014WO2014122220A1 Induction of cross-reactive cellular response against rhinovirus antigens
08/14/2014WO2014121449A1 Preparing tooth-like structure using stem cell
08/14/2014WO2014121436A1 Transgenic plants
08/14/2014WO2014060610A3 Antimicrobial peptides
08/14/2014US20140230081 Polynucleotide, polypeptide, animal model and method for the development of complement system modulators
08/14/2014US20140228558 Method and device for optimizing a nucelotide sequence for the purpose of expression in a protein
08/14/2014US20140228542 Method For Producing Peptide Fractions And Use Thereof
08/14/2014US20140228540 Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
08/14/2014US20140228539 Separation of acetylated proteins from unacetylated proteins
08/14/2014US20140228298 Methods, systems, and compositions for calpain inhibition
08/14/2014US20140228294 Natriuretic polypeptides with unique pharmacologic profiles
08/14/2014US20140228293 Parathyroid hormone analogs, compositions and uses thereof
08/14/2014US20140228292 Long acting biologically active luteinizing hormone (lh) compound
08/14/2014US20140228289 Modified and stabilized gdf propeptides and uses thereof
08/14/2014US20140228285 Multi-Substituted Insulins
08/14/2014US20140228282 Fibroblast growth factor 21 proteins
08/14/2014US20140228279 Cationic peptidopolysaccharides with excellent broad- spectrum antimicrobial activities and high selectivity
08/14/2014US20140228238 Genes and polypeptides relating to breast cancers
08/14/2014US20140227782 Thermosensitive, bioactive biopolymer and associated method of cell harvesting
08/14/2014US20140227767 Peptides and methods for inducing cell death
08/14/2014US20140227766 Purification of biological products by constrained cohydration chromatography
08/14/2014US20140227741 Biological Systems for Production of Highest Quality Proteins
08/14/2014US20140227740 Degradable Clostridial Toxins
08/14/2014US20140227723 Engineered microbe-targeting molecules and uses thereof
08/14/2014US20140227718 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting g protein coupled receptors using the same
08/14/2014US20140227713 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt
08/14/2014US20140227698 Use of fmn-binding fluorescence proteins (fbfp) as new types of secretion markers
08/14/2014US20140227322 Rabies virus like particle production in plants
08/14/2014US20140227315 Novel Chimeric Proteins and Methods for Using The Same
08/14/2014US20140227314 Engineered Type IV Pilin of Clostridium difficile
08/14/2014US20140227313 Group a streptococcal m-related proteins and methods of use
08/14/2014US20140227312 A1 moiety of cholera toxin a subunit as an adjuvant for mucosal and systemic vaccines
08/14/2014US20140227311 Method for Removing Immunosuppressive Properties of HIV Envelope Glycoproteins
08/14/2014US20140227308 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
08/14/2014US20140227306 Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
08/14/2014US20140227304 Vaccines for preventing and treating alzheimer's disease
08/14/2014US20140227280 Protein complex comprising mcm8 and mcm9 proteins and their use
08/14/2014US20140227279 Methods and compositions for the treatment of autoimmune and inflammatory diseases
08/14/2014US20140227278 Antibodies to human signal peptide-containing proteins
08/14/2014US20140227275 Methods of treating and diagnosing pancreatitis
08/14/2014US20140227274 Prevention and Treatment of Amyloidogenic Disease
08/14/2014US20140227268 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)
08/14/2014US20140227266 NOGO Receptor Antagonists
08/14/2014US20140227265 Method of treating or ameliorating metabolic disorders using clec-2
08/14/2014US20140227264 Drug fusions and conjugates with extended half life
08/14/2014US20140227263 Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2
08/14/2014US20140227254 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
08/14/2014US20140227223 Pegylated Interleukin-10
08/14/2014DE102013202206A1 Methode zur Inhibierung des Proteins SWAP-70 Method for inhibiting protein SWAP-70
08/13/2014EP2765198A2 Isoprenoid production by genetically modified chloroplasts
08/13/2014EP2765195A1 Methods and compositions for gene inactivation
08/13/2014EP2765193A1 Chimeric antigen receptor
08/13/2014EP2765140A2 Cadherin-2 or Mucin-13 binding molecules for cancer treatment
08/13/2014EP2765139A2 Natriuretic polypeptides
08/13/2014EP2765138A2 HIV-1 envelope glycoprotein
08/13/2014EP2765137A1 Induction of cross-reactive cellular response against rhinovirus antigens
08/13/2014EP2764099A1 Ecm composition, tumor microenvironment platform and methods thereof
08/13/2014EP2764019A2 Dual function proteins for treating metabolic disorders
08/13/2014EP2764018A1 Self-assembling polypeptide polyhedra
08/13/2014EP2764017A2 Compositions and methods for conferring herbicide resistance
08/13/2014EP2764016A1 Regulatable promoter
08/13/2014EP2764015A1 Influenza hemagglutinin variants
08/13/2014EP2764014A2 Adenoviral vectors and methods of use
08/13/2014EP2764013A2 Adenoviral vectors and methods of use
08/13/2014EP2764012A2 Adenoviral vectors and methods of use
08/13/2014EP2764011A2 Adenoviral vector-based respiratory syncytial virus (rsv) vaccine
08/13/2014EP2764009A1 Peptides for use in the treatment of il-1 related diseases and conditions
08/13/2014EP2763696A2 Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped rna viruses
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 2916